ID
29869
Description
Study ID: 102587 Clinical Study ID: EGF102587 Study Title: A Single-Dose, Open-Label, Randomized, Three-Way Cross-Over Study in Healthy Subjects to Evaluate the Relative Bioequivalence of Two New Small Tablet Formulations of Lapatinib (GW572016) Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tykerb,Tycerb,Tyverb; Tyverb,Tykerb,Tycerb Study Indication: Neoplasms, Breast Documentation part: Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results
Keywords
Versions (1)
- 4/24/18 4/24/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
April 24, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Study to Evaluate the Relative Bioequivalence of Two New Small Tablet Formulations of Lapatinib in Healthy Subjects 102587
Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results
Description
Relevant medical conditions/Risk factors
Alias
- UMLS CUI-1
- C0262926
- UMLS CUI-2
- C0035648
- UMLS CUI-3
- C1519255
Description
MHx Sequence Number
Data type
integer
Alias
- UMLS CUI [1]
- C2348184
Description
Specific Condition Name
Data type
text
Alias
- UMLS CUI [1]
- C0012634
Description
Date of onset
Data type
date
Alias
- UMLS CUI [1]
- C0574845
Description
Specific Condition Continuing
Data type
integer
Alias
- UMLS CUI [1]
- C0012634
Description
Date of last occurrence
Data type
date
Alias
- UMLS CUI [1,1]
- C2745955
- UMLS CUI [1,2]
- C0012634
- UMLS CUI [1,3]
- C0011008
Description
Relevant medical conditions/Risk factors
Data type
text
Alias
- UMLS CUI [1]
- C0262926
- UMLS CUI [2]
- C0035648
Description
Relevant diagnostic results
Alias
- UMLS CUI-1
- C0430022
- UMLS CUI-2
- C0456984
- UMLS CUI-3
- C1519255
Description
Lab Sequence Number
Data type
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C2348184
Description
Test Name
Data type
text
Alias
- UMLS CUI [1]
- C0022885
Description
Test Date
Data type
date
Alias
- UMLS CUI [1]
- C2826641
Description
Test Result
Data type
text
Alias
- UMLS CUI [1]
- C0587081
Description
Test Units
Data type
text
Alias
- UMLS CUI [1,1]
- C1519795
- UMLS CUI [1,2]
- C0587081
Description
Normal Low Range
Data type
text
Alias
- UMLS CUI [1]
- C0086715
Description
Normal High Range
Data type
text
Alias
- UMLS CUI [1]
- C0086715
Description
Relevant diagnostic results not noted above
Data type
text
Alias
- UMLS CUI [1]
- C0587081
Description
event recurrence
Data type
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0034897
Similar models
Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results
C0087111 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
C2347852 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0035648 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
C0012634 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0035648 (UMLS CUI [2])
C0456984 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
C2348184 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0034897 (UMLS CUI [1,3])
No comments